Association of the costimulatory molecule gene polymorphisms and active cytomegalovirus infection in hematopoietic stem cell transplant patients

[1]  M. Karimi,et al.  Association of the Co-stimulatory Molecules Polymorphisms with CMV Infection in Liver Transplant Recipients , 2011, International journal of organ transplantation medicine.

[2]  Qianqian Zhu,et al.  CTLA-4 exon 1 +49 polymorphism alone and in a haplotype with −318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients , 2011, Molecular Biology Reports.

[3]  A. Ghaderi.  CTLA4 gene variants in autoimmunity and cancer: a comparative review. , 2011, Iranian journal of immunology : IJI.

[4]  Sai Lou,et al.  Association of polymorphisms of programmed cell death-1 gene with chronic hepatitis B virus infection. , 2010, Human immunology.

[5]  D. Olive,et al.  B and T Lymphocyte Attenuator Is Highly Expressed on CMV-Specific T Cells during Infection and Regulates Their Function , 2010, The Journal of Immunology.

[6]  Henrietta Seet,et al.  Comparison of QIAGEN automated nucleic acid extraction methods for CMV quantitative PCR testing. , 2010, American journal of clinical pathology.

[7]  R. Uibo,et al.  Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease rates. , 2009, Human immunology.

[8]  J. Zaia,et al.  Increased programmed death-1 molecule expression in cytomegalovirus disease and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  Jih-Luh Tang,et al.  Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[10]  C. Pietrangeli,et al.  Delayed onset CMV disease in solid organ transplant recipients. , 2009, Transplant immunology.

[11]  J. Esteve,et al.  CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy , 2009, Leukemia.

[12]  B. Gärtner,et al.  PD‐1 Expression and IL‐2 Loss of Cytomegalovirus‐ Specific T Cells Correlates with Viremia and Reversible Functional Anergy , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  A. Toubert,et al.  Donor CTLA-4 +49 A/G*GG genotype is associated with chronic GVHD after HLA-identical haematopoietic stem-cell transplantations. , 2007, Blood.

[14]  C. Mengelle,et al.  Alteration of direct and indirect effects of cytomegalovirus. , 2007, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

[15]  X. Li,et al.  Striking Dichotomy of PD‐L1 and PD‐L2 Pathways in Regulating Alloreactive CD4+ and CD8+ T Cells In Vivo , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  T. Berg,et al.  Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease , 2007, European journal of gastroenterology & hepatology.

[17]  R. Rubin.  The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the ‘silo hypothesis’ , 2007, Current opinion in infectious diseases.

[18]  K. Schilbach,et al.  PD-1–PD-L1 Pathway Is Involved in Suppressing Alloreactivity of Heart Infiltrating T Cells During Murine GVHD Across Minor Histocompatibility Antigen Barriers , 2007, Transplantation.

[19]  Marcos González,et al.  CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. , 2007, Blood.

[20]  P. P. Paricio,et al.  Tolerancia y quimerismo en el trasplante hepàtico , 2007 .

[21]  A. Mackensen,et al.  Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion , 2007, Cancer Immunology, Immunotherapy.

[22]  A. Limaye,et al.  Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease. , 2007, The Journal of infectious diseases.

[23]  Haidong Dong,et al.  Costimulation, coinhibition and cancer. , 2007, Current cancer drug targets.

[24]  Seyed Mohsen Mousavi,et al.  Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to chronic hepatitis B. , 2006, World journal of gastroenterology.

[25]  A. Rudensky,et al.  Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM). , 2005, Blood.

[26]  R. Yaghobi,et al.  Comparative analysis of a double primer PCR assay with plasma, leukocytes and antigenemia for diagnosis of active human cytomegalovirus infection in bone marrow transplant patients , 2005, Bone Marrow Transplantation.

[27]  D. Stuart,et al.  Crystal structure of a soluble CD28-Fab complex , 2005, Nature Immunology.

[28]  S. O’Brien,et al.  Cytotoxic T-Lymphocyte Antigen 4 Gene and Recovery from Hepatitis B Virus Infection , 2004, Journal of Virology.

[29]  Lieping Chen.  Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity , 2004, Nature Reviews Immunology.

[30]  W. Hop,et al.  Recipient CTLA‐4 +49 G/G Genotype Is Associated with Reduced Incidence of Acute Rejection After Liver Transplantation , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[31]  A. Panoskaltsis-Mortari,et al.  Blockade of Programmed Death-1 Engagement Accelerates Graft-Versus-Host Disease Lethality by an IFN-γ-Dependent Mechanism1 , 2003, The Journal of Immunology.

[32]  Y. Lee,et al.  Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene. , 2002, Chest.

[33]  Z. Bentwich,et al.  CTLA-4 upregulation during aging , 2002, Mechanisms of Ageing and Development.

[34]  Shiho Watanabe,et al.  Opposing Effects of Anti-Activation-Inducible Lymphocyte- Immunomodulatory Molecule/Inducible Costimulator Antibody on the Development of Acute Versus Chronic Graft-Versus-Host Disease1 , 2001, The Journal of Immunology.

[35]  Pascale Jeannin,et al.  A soluble form of CTLA‐4 generated by alternative splicing is expressed by nonstimulated human T cells , 1999, European journal of immunology.

[36]  J. Fung.  Tolerance and chimerism in liver transplantation. , 1997, Transplantation proceedings.

[37]  J. Klein,et al.  IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE , 1997, British journal of haematology.

[38]  T. Honjo,et al.  Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. , 1996, International immunology.

[39]  M. Boeckh,et al.  Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. , 1992, Blood.

[40]  M. Lefranc,et al.  Human Ig superfamily CTLA‐4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA‐4 cytoplasmic domains , 1988, European journal of immunology.

[41]  R Storb,et al.  Bone-marrow transplantation (second of two parts). , 1975, The New England journal of medicine.

[42]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.

[43]  M. Boeckh,et al.  after allogeneic marrow transplantation Cytomegalovirus antigen detection in peripheral blood leukocytes , 2011 .

[44]  X. Gu,et al.  +49G > A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population. , 2010, Human immunology.

[45]  D. Olive,et al.  Infection and Regulates Their Function Expressed on CMV-Specific T Cells during B and T Lymphocyte Attenuator Is Highly , 2010 .

[46]  Zhongdong Chen,et al.  Association of Cytotoxic T Lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer , 2009, Molecular Biology Reports.

[47]  J. Zaia,et al.  Increased PD-1 expression in CMV disease and acute GVHD after allogeneic HCT , 2009 .

[48]  A. Limaye,et al.  Programmed death-1 expression in liver transplant recipients as a prognostic indicator of cytomegalovirus disease. , 2008, The Journal of infectious diseases.

[49]  R. Nuscher,et al.  Bone marrow transplantation. , 1977, The American journal of nursing.